Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III(AUS/FLUS)by Thyroid Fine-Needle Aspiration(FNA)Could be Assisted by Tumor Size for Precision Treatment

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04601298
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:15.896727+00:00
Published At
2021-03-17T00:00:00+00:00
Record Updated At
2021-03-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Thyroid Cancer", "Atypia of Undetermined Significance", "FLUS"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-03-17"
protocolSection.identificationModule.nctId
"NCT04601298"
protocolSection.identificationModule.officialTitle
"The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III\uff08AUS/FLUS\uff09by Thyroid Fine-Needle Aspiration\uff08FNA\uff09Could be Assisted by Tumor Size for Precision Treatment"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Thyroid Cancer (protocolSection.conditionsModule.conditions)
  • Atypia of Undetermined Significance (protocolSection.conditionsModule.conditions)
  • FLUS (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.